O-RAN Alliance Conducts First Global Plugfest to Foster Adoption of Open and Interoperable 5G Radio Access Networks
19.12.2019 13:57:00 EET | Business Wire | Press release
The O-RAN Alliance successfully conducted its first worldwide plugfest and proof of concept to demonstrate the functionality as well as the multi-vendor interoperability of network equipment that complies with the recently published O1, A1, and Open Fronthaul interface specifications.
“O-RAN’s first global plugfest showcases the power of the community to document and develop truly open interface specifications with the potential to accelerate new 5G advanced services that will be multi-operator, multi-vendor, and create opportunities for the entire ecosystem,” said Andre Fuetsch, Chairman of the O-RAN Alliance and Chief Technology Officer of AT&T. “These live demonstrations represent yet another step toward the realization of O-RAN compliant 5G RAN solutions that should soon become part of the product offerings of both mainstream and niche vendors.”
ASIA
Hosted by China Mobile, the plugfest Asian Session was held in the China Mobile International Information Port, an Open Test and Integration Center, with physical attendance well over 200 attendees from over 70 companies, plus on-line attendance of over 70 participants. Representatives from global operators including British Telecom, China Telecom, China Unicom, NTT DOCOMO, Orange, Reliance Jio, Telecom Italia Mobile and an operator from North America have actively participated in this event. The plugfest tested and integrated multi-vendor solutions that comply with the O-RAN Open Fronthaul interface and exercised decoupling different hardware technologies from the RAN software:
- Cloud-based small cell running on virtualization technology was demonstrated by CertusNet, Lenovo, ChengDu NTS and Inventec. It features a VM-based O-CU and containerized O-DU cohosted on the same x86 processor plus accelerator platform.
- Multi-vendor interoperability with 5G commercial products was demonstrated by NTT DOCOMO with Fujitsu and NEC.
- A low power configuration of cloud base station running on Yocto OS and container technology was demonstrated by Altran, ArrayComm, WindRiver, Baicells and CIG. It features the open architecture baseband signal processing based on ARM processor plus accelerator computing platform.
- Soft base station with O-RAN compliant open fronthaul interface, but without virtualization, was demonstrated by Radisys, Foxconn (Taiwan), QCT and Intel. It leverages open source software including the O-RAN Open Source Community’s OFH Lib, and BBDev based Accelerator Abstraction Layer SDK API.
- The interworking of the O-RAN open fronthaul interface was demonstrated on technology provided by FHK (Shenzen) and Viavi, which performs comprehensive tests based on the test specification by O-RAN with O-RU and UE emulator in a multiple-UE test environment.
The plugfest held in the NTT DOCOMO R&D Center presented multi-vendor interoperability between CU/O-DU and O-RU using the O-RAN Open Fronthaul interface and multi-vendor interoperability between eNB and gNB using the O-RAN X2 interface. The functionality has been successfully demonstrated by NTT DOCOMO, Fujitsu, NEC, and Nokia. NTT DOCOMO has already started 5G pre-commercial service with the presented products. An Open Test and Integration Center is planned to be established in Japan.
NORTH AMERICA
The plugfest and proof-of-concept conducted within an Open Test and Integration Center candidate in North America, 5G COSMOS, which consists of vendor and university labs in the NYC metro area, was hosted by AT&T and focused primarily on the validation of the O1 and A1 interfaces:
- Physical Network Function (PNF) Plug and Play, a 3GPP-aligned O1 use case that provides a means for service providers to collaborate with equipment vendors to have PNFs discovered by Service Management Orchestration (SMO) via a PNF registration handler, was demonstrated by Nokia, CommScope and Ericsson. Remote SMO functions were also demonstrated with connections to labs in France and Germany.
- Bulk Performance Management Data Collection was demonstrated by Ericsson and Nokia.
- O1 interface functionality for Configuration, Performance, and Fault Management of multi-vendor equipment via a vendor-agnostic SMO was demonstrated by Altiostar, CommScope, and Samsung.
- A1 interface functionality to optimize PCI/RSI for a large-scale RAN simulator using a closed loop automation framework was demonstrated by IBM, Tech Mahindra, Wipro and highstreet technologies.
- Convergence of the Open Fronthaul Management Plane specification with O1 interface was demonstrated by Samsung.
“The O-RAN Alliance has been continuously expanding its influence in the industry since its inception. It is really amazing to see such a symbolic milestone achieved just 10 months since its release of the first specification in MWC Barcelona this year,” said Zhengmao Li, EVP of China Mobile. “The successful holding of the plugfest event globally with deep contribution from over 30 partners represents a consolidated step towards a full disaggregated O-RAN compliant 5G network.”
Dr. Hiroshi Nakamura, EVP and CTO, NTT DOCOMO commented, "We believe wide adoption of O-RAN compliant products will enable more agile, flexible and cost-effective network construction, and welcome the testing and integration efforts of O-RAN standards that are being carried out across the globe. NTT DOCOMO will continue to lead O-RAN Alliance activities and expand its 5G network, and will accelerate the co-creation of 5G services and markets with vertical industry partners."
O-RAN Industry Briefing at MWC 2020
For a comprehensive update on O-RAN activities, including significant developments in Europe, the O-RAN community will come together for the O-RAN Industry Briefing event at MWC Barcelona 2020. Representatives from O-RAN operator and vendor member organizations will discuss and share views on the important steps towards realizing O-RAN compliant commercial solutions. O-RAN Alliance is looking forward to meeting you on Feb 25, 2020, 9:30-10:30 am at the Deutsche Telekom Booth, Hall 3, Booth 3M31.
About O-RAN Alliance
O-RAN Alliance is a world-wide community of more than 130 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, O-RAN Alliance’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN standards will enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN-compliant mobile networks will at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, O-RAN Alliance publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.
For more information please visit www.o-ran.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191219005289/en/
Contact information
O-RAN Alliance PR Contact
Zbynek Dalecky
pr@o-ran.org
O-RAN Alliance e.V.
Buschkauler Weg 27
53347 Alfter/Germany
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 08:00:00 EEST | Press release
Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufacturing site. All other aspects of the BLA, including safety- and efficacy-related parts, did not solicit deficiencies to be addressed. The FDA made observations during the PLI for which Galderma is putting in place corrective and preventive actions. Galderma will also be seeking further guidance through continued open dialogue with the FDA toward resolution of the relevant observations. Galderma plans to rapidly respond to the CRL and advancing RelabotulinumtoxinA in the U.S. remains a top priority. The ob
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 04:45:00 EEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 02:56:00 EEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
